Multi-target, multi-channel, strengthening the foundation three methods treatment of myasthenia gravis

Researchers established animal model of experimental autoimmune myasthenia gravis,treatment of myasthenia gravis the experimental studies have shown: Powerful bulk ginseng can significantly improve symptoms, improve muscle strength and EMG potentials attenuation rat model, specific inhibition of antibodies against the acetylcholine receptor and T cell proliferation, decreased damage acetylcholine receptors, but does not inhibit normal immune function EAMG rats, indicating a strong ginseng powder in treating EAMG immunosuppressive mechanism is different from Western medicine, but rather to achieve a therapeutic effect by modulating the immune balance.
Stem cell immune induction therapy:
Using the world's most advanced "Mesenchymal stem cell transplantation" immunization induction, mesenchymal stem cells transplanted into the patient's body, to suppress the immune response of T cells through the secretion of growth factors, thereby functioning immune reconstitution, to improve their immune function, to correct immune abnormalities. With good efficacy, short course, less damage, less pain, fewer side effects and other advantages. Not only symptoms improved significantly after transplantation, a good short-term effect, but also further improve the clinical efficacy of long-term, but also reduce recurrent disease, quality of life improved significantly.
Supernatural tone off acupuncture:
Including Jiaji Points big moxibustion, plum-blossom needle method, ointment rubbed moxibustion method, acupuncture meridians clearance method and so on.
We are guided by scientific, rigorous, realistic, pragmatic, safe, and effective principles, take the road Integrative treatment characteristics, to more advanced studies in patients with myasthenia gravis friend effective treatment methods, giving them new light and I hope and wish that all patients with myasthenia gravis speedy recovery!

http://www.tcminchina.com/news/Treatment-of-Myasthenia-Gravis-218.html